Pluricell Biotech

Best Biotech Start-Up - Brazil
Award for Innovation in Stem Cell Therapy
Winners image
<p>PluriCell Biotech is a preclinical stage biotechnology company developing curative cell therapies for chronic disorders. Currently we are focused on the development of lab made human heart cells to treat heart failure patients. With our exclusive technology, PluriCell wants to produce human heart cells at 1% of COGs and provide a curative therapy for patients at half the cost to the health care system. Additionally, PluriCell is able to develop cell treatments to address chronic disorders in different areas such as neurology, ophthalmology and potentially cancer.</p>